ABEMACICLIB LACKS A CLINICALLY-MEANINGFUL EFFECT ON CYP1A2, CYP2C9, CYP2D6, AND CYP3A4 SUBSTRATES IN PATIENTS WITH CANCER.P. K. Turner,S. D. Hall,P. Kulanthaivel, S. C. Tate, J. Rehmel, J. Royalty, Y. Guo-Avrutin,A. Y. ChiangCLINICAL PHARMACOLOGY & THERAPEUTICS（2019）引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
